Evidence map›Paper›PMID 34770791›Full record

ArticleMolecules (Basel, Switzerland)2021

Pan-ROCK and ROCK2 Inhibitors Affect Dexamethasone-Treated 2D- and 3D-Cultured Human Trabecular Meshwork (HTM) Cells in Opposite Manners.

Megumi Watanabe, Yosuke Ida, Masato Furuhashi, Yuri Tsugeno, Fumihito Hikage, Hiroshi Ohguro

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. All-International journal of molecular sciences · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Megumi WatanabeDepartments of Ophthalmology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.ORCID 0000-0002-8026-6532
Yosuke IdaDepartments of Ophthalmology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.ORCID 0000-0002-5165-6507
Masato FuruhashiDepartments of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.ORCID 0000-0002-0145-3541
Yuri TsugenoDepartments of Ophthalmology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.
Fumihito HikageDepartments of Ophthalmology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.ORCID 0000-0002-0124-5494
Hiroshi OhguroDepartments of Ophthalmology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.
Sapporo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Effects of a pan-ROCK-inhibitor, ripasudil (Rip), and a ROCK2 inhibitor, KD025 on dexamethasone (DEX)-treated human trabecular meshwork (HTM) cells as a model of steroid-induced glaucoma were investigated. In the presence of Rip or KD025, DEX-treated HTM cells were subjected to permeability analysis of 2D monolayer by transendothelial electrical resistance (TEER) and FITC-dextran permeability, physical properties, size and stiffness analysis (3D), and qPCR of extracellular matrix (ECM), and their modulators. DEX resulted in a significant increase in the permeability, as well as a large and stiff 3D spheroid, and those effects were inhibited by Rip. In contrast, KD025 exerted opposite effects on the physical properties (down-sizing and softening). Furthermore, DEX induced several changes of gene expressions of ECM and their modulators were also modulated differently by Rip and KD025. The present findings indicate that Rip and KD025 induced opposite effects toward 2D and 3D cell cultures of DEX-treated HTM cells.

Indexed as

BiomarkersCell Culture TechniquesCells, CulturedDexamethasoneExtracellular MatrixExtracellular Matrix ProteinsHumansProtein Kinase Inhibitorsrho-Associated KinasesTrabecular MeshworkBiomarkersDexamethasoneExtracellular Matrix ProteinsProtein Kinase Inhibitorsrho-Associated KinasesROCK1 protein, humanROCK2 protein, human3D spheroid culturesdexamethasonehuman trabecular meshwork (HTM)KD025Rho-associated coiled-coil containing protein kinase (ROCK)ripasudil

Identifiers

PMID34770791
PMCPMC8587022
OpenAlexW3209543327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.